Clinical TrialID 6920
A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris
NCT02578043
Acne Vulgaris
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6920
- Evidence Id
- 6920
- Core Evidence Id
- 6920
- Source Clinical Trial Id
- 6912
- Herb2 Clinical Trial Id
- HBCT006912
- Nct Id
- NCT02578043
- Title
- A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris
- Status
- Completed
- Phase
- Phase 1
- Study Result
- No
- Study Condition
- Acne Vulgaris
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75%|DRUG: Onexton™ Gel|DRUG: Placebo
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Child, Adult
- Enrollment
- 844
- Outcome Measure
- Demonstration of Bioequivalence, Demonstration of Bioequivalence in percent change in inflammatory and non-inflammatory lesion counts, Week 12
- Sponsor Collaborator
- Taro Pharmaceuticals USA
- Funded By
- INDUSTRY
- Location
- Other Id
- CLBG 1508
- Start Date
- 2015-04
- Primary Completion Date
- 2015-08
- Completion Date
- 2015-09
- First Posted
- 2015-10-16
- Results First Posted
- Last Update Posted
- 2018-05-18
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT02578043
- Title Cn
- Title En
- A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris
- Bilingual Status
- semi_complete